Breaking News

Indicia Production Acquires METIS Biotechnologies

Flow cytometry technology developed by METIS will complement Indicia's current offering in microbiological analyses

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Indicia Production, a company specialized in the manufacture of ready-to-use culture media and sterile liquid products, has acquired METIS Biotechnologies, a company that develops, produces and markets rapid microbiological analysis solutions using flow cytometry. Financial terms were not disclosed. METIS Biotechnologies’ analytical solutions can be automated from sampling to results rendering. They are applicable for the pharmaceutical, food processing and cosmetics industries. The instrumen...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters